Metabolic syndrome in black people of the African diaspora: The paradox of current classification, definition and criteria

Ethnicity and Disease

Volumn 19, Issue 2 SUPPL.2, 2009, Pages

  Gaillard, Trudy ^a   Schuster, Dara ^a   Osei, Kwame ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

African diaspora; HDL cholesterol; Insulin resistance; Metabolic syndrome; Triglycerides

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; LIPID;

BODY COMPOSITION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY DISEASE; CONFERENCE PAPER; DISEASE CLASSIFICATION; HUMAN; INSULIN RESISTANCE; METABOLIC SYNDROME X; NEGRO; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; RISK FACTOR; TRIACYLGLYCEROL BLOOD LEVEL; AFRICAN AMERICAN; BLOOD; BLOOD PRESSURE; BODY MASS; CLASSIFICATION; ETHNOLOGY; FEMALE; GLUCOSE BLOOD LEVEL; MALE; METABOLISM; PHYSIOLOGY; REVIEW; STATISTICS; WAIST CIRCUMFERENCE;

AFRICAN AMERICANS; BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; FEMALE; HUMANS; LIPIDS; MALE; METABOLIC SYNDROME X; RISK FACTORS; WAIST CIRCUMFERENCE;

EID: 80053191303     PISSN: 1049510X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (39)

1. Misra A, Khurana L. Obesity and the metabolic syndrome in developing countries. J Clin Endocrinol Metab. 2008;93:S9-S30.
2. Murray C, Lopez A. The Global Burden of Disease: A Comprehensive Assessment of Mortality and Disability from Diseases, Injuries, and Risk Factors in 1990 and Projected to 2020. Boston, Mass: Harvard School of Public Health; 1996.
3. Osei K. Metabolic consequences of West African Diaspora: lessons from the thrifty gene. J Lab Clin Med. 1999;133:98-112.
4. Osei K, Schuster D. Effects of ethnicity and race on insulin sensitivity, ambulatory blood pressure and heart rates in three ethnic populations: comparative studies in African Americans, Ghanaian immigrants and White Americans. Am J Hypertens. 1996;9:1157-1164. (Pubitemid 26423638)
5. Gillum R, Mussolino M, Madans J. Diabetes mellitus, coronary heart disease incidence, and death from all cause in African American and European American women. The NHANES I Epidemiologic Follow-up Study. J Clin Epidemiol. 2000;53:511-518. (Pubitemid 30254348)
6. Meis SB, Schsuter D, Gaillard T, Osei K. Metabolic syndrome in non-diabetic, obese first degree relatives of African American patients with type 2 diabetes. African American triglycerides-HDL-and insulin resistance paradox. Ethn Dis. 2006;16:830-836.
7. Sumner AE, Finley KB, Genovese DJ, Criqui MH, Boston RC. Fasting triglyceride and the TG/HDL ratio are not markers of insulin resistance in African Americans. Arch Intern Med. 2005;165:1395-1400. (Pubitemid 40973422)
8. Sumner AE, Vega GL, Genovese DJ, Finley KB, Bergman RN, Boston RC. Normal triglyceride levels despite insulin resistance in African Americans: role of lipoprotein lipase. Metabolism. 2005;54:902-909. (Pubitemid 40827206)
9. Amoah ABG, Owusu SK, Schuster DP, Gaillard T, Osei K. Insulin sensitivity and cardiovascular risk factors in hypertensive and normotensive native Ghanaians. Diabetologia. 2003;46:949-955. (Pubitemid 36961318)
10. Osei K. Insulin resistance and systemic hypertension. Am J Cardiol. 1999;84:331-361.
11. Grundy S. Obesity, metabolic syndrome and cardiovascular disease. J Clin Endocrinol Metab. 2004;89:2595-2600. (Pubitemid 38766337)
12. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA. 2002;287:356-359. (Pubitemid 34251969)
13. Park YW, Zhu S, Palaniappan L, Heshka S, Carnethon MR, Heymsfield SB. The metabolic syndrome: prevalence and associated risk factor findings in the US population from the third National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med. 2003;24:427-362.
14. Executive summary of the third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285:2486-2497.
15. Osei K, Schuster DP. Metabolic characteristics of African descendants: a comparative study of African-Americans and Ghanaian immigrants using minimal model analysis. Diabetologia. 1995;38:1103-1109.
16. Ntyintyane L, Panz V, Raal F. The metabolic syndrome using the National Cholesterol Education Program and International Diabetes Federation definitions among urbanised Black South Africans with established coronary artery disease. Journal of Endocrinology, Metabolism and Diabetes of South Africa. 2007;12:6-12.
17. Isezuo S, Ezunu E. Demographic and clinical correlates of metabolic syndrome in Native African type-2 diabetic patients. J Nat Med Assoc. 2005;97:557-563. (Pubitemid 40463586)
18. Motala A, Esterhuizen T, Gouws E, Pirie F, Omar M. Diabetes and other disorders of glycemia in a rural South African community. Diabetes Care. 2008;31:1783-1788.
19. Taylor H, Liu J, Wilson G, et al. Distinct component profiles and high risk among American Americans with the metabolic syndrome. The Jackson Heart Study. Diabetes Care. 2008;31:1248-1252.
20. Amoah ABG, Owusu SK, Schuster DP, Gaillard T, Osei K. Insulin resistance, beta cell function and cardiovascular risk in Ghanaians with varying degrees of glucose tolerance. Ethn Dis. 2002;12:S3-10-S3-17.
21. Fezeu L, Baikau B, Kengne A, Sobngwi E, Mbanya J. Metabolic syndrome in a sub- Saharan African setting: central obesity may be the key determinant. Atherosclerosis. 2007;193: 70-76. (Pubitemid 46776712)
22. Tillin T, Forouhi N, Johnston D, McKeigue P, Chaturvedi N, Godsland I. Metabolic syndrome and coronary heart disease in South Asians, African-Caribbeans and white Eupopeans: a UK population-based cross-sectional study. Diabetologia. 2005;48:649-656. (Pubitemid 40591219)
23. Osei K, Schuster D. Ethnic differences in secretion, sensitivity and hepatic extraction of insulin in Black and White Americans. Diabet Med. 1994;11:755-762. (Pubitemid 24319774)
24. Gaillard T, Schuster D, Osei K. Independent role of blood pressure on cardiovascular risk factors in nondiabetic, obese African American women with family history of type 2 diabetes: implications for metabolic syndrome components. J Am Soc Hypertens. 2009;23:25-35.
25. Haffner S, D'Agistino R, Goff D, et al. LDL size in African Americans, Hispanics and Non- Hispanic Whites: the Insulin Resistance Atherosclerosis Study. Arteriol Thromb Vasc Biol. 1999;39:2234-2240. (Pubitemid 29422257)
26. Jennings C, Lambert E, Collins M, Joffe Y, Levitt N, Groedecke J. Determinants of insulin-resistant phenotypes in normal weight and obese Black African women. Obesity. 2008;10:1-8.
27. Crowther NJ, Ferris WF, Ojwang PJ, Rheeder P. The effect of abdominal obesity on insulin sensitivity and serum lipid and cytokine concentrations in African Women. Clin Endocrinol. 2006;64:535-541.
28. Albu JB, Murphy L, Frager DH, Johnson JA, Pi-Sunyer FX. Visceral fat and race dependant health risks in obese nondiabetic premenopausal women. Diabetes. 1997;46: 456-462. (Pubitemid 27090276)
29. Cowie CC, Howard BV, Harris MI. Serum lipoproteins in African Americans and Whites with noninsulin-deoendent diabetes in the US population. Circulation. 1991;90:1185-1191.
30. Lewis G, Rader D. New insights into the regulation of HDL metabolism and reverse cholesterol transport. Circ Res. 2005;96:1221-1232. (Pubitemid 40962099)
31. Jaichander P, Selvarajan K, Garelnabi M, Parathasarathy S. Induction of paraoxonase 1 and apolipoprotein A1 gene expression by aspirin. J Lipid Res. 2008;49:2142-2148.
32. Parthasarathy S, Barnett J, Fong L. High density lipoprotein inhibits the oxidative modification of low density lipoprotein. Biochim Biophys Act. 1990;1044:275-281.
33. Lopes H, Morrow J, Stojiljkovic M, Goodfriend T, Egan B. Acute hyperlipidemia increases oxidative stress more in African Americans than in White Americans. Am J Hypertens. 2003;16:331-336. (Pubitemid 36570967)
34. Weyer C, Funahashi T, Tanaka S, et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab. 2001;86:1930-1935. (Pubitemid 32472900)
35. Ferris WF, Naran NH, Crowther NJ, Rheeder P, van der Merwe L, Cherry N. The relationship between insulin sensitivity and serum adiponectin levels in three population groups. Hormone Metab. 2005;11:695-701. (Pubitemid 41810493)
36. Schutte A, Huisman H, Schutte R, et al. Differences and similarities regarding adiponectin investigated in African and Caucasian women. Eur J Endocrinol. 2004;157:181-188. (Pubitemid 47233122)
37. Duncan BB, Schmidt MI, Pankow JS, et al. Adiponectin and the development of type 2 diabetes. The Atherosclerosis Risk in Communities Study. Diabetes. 2004;53:2473-2478. (Pubitemid 39145606)
38. Hulver MW, Saleh O, MacDonald KG, Poeries WJ, Barakat HA. Ethnic differences in adiponectin levels. Metabolism. 2004;53:1-5.
39. Lea J, Cheek D, Thomley-Brown D, et al. Metabolic syndrome, proteinuria and the risk of Progressive CKD in hypertensive African Americans. Am J Kidney Dis. 2008;51:732-740. (Pubitemid 351626250)